Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5537026 | Vaccine | 2017 | 8 Pages |
Abstract
Abnormal behavior Type A was more likely to develop up to approximately 30 times during the period between the initial intake of oseltamivir and Tmax. However, this period overlapped with the early period of influenza where high fever was observed. Since useful approaches to control the influence of the natural disease course of influenza were not available in this study, we could not deny the possibility that abnormal behavior was induced by influenza itself. The SCCS study was not an optimal method to evaluate the relationship between oseltamivir use and abnormal behavior.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Wakaba Fukushima, Kotaro Ozasa, Akihisa Okumura, Masaaki Mori, Mitsuaki Hosoya, Takashi Nakano, Takuya Tanabe, Naoto Yamaguchi, Hiroshi Suzuki, Mitsuru Mori, Hideaki Hatayama, Hirotaka Ochiai, Kyoko Kondo, Kazuya Ito, Satoko Ohfuji, Yosikazu Nakamura,